Christiaan.......Incorrect.....
It will generate revenue, but whatever revenue.... it will offset against expense........so no profit, but will slow cash burn quite nicely.
MMD and HARS will be big for INSM, but will be a bit....
ALS is a wilcard, but likely in quite a longshot.....
Bio-generics........HUGE.